ISO 15189 CAP logo

September 15, 2025

ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program

ARUP is the largest lab to receive reaccreditation under the updated ISO 15189 standard, an achievement that highlights the company’s technical excellence, commitment to quality, and innovation.

Illustration of the biomarker pTau 217.

The biomarker pTau 217 is associated with Alzheimer’s disease pathology and can be detected in plasma, providing a minimally invasive option to support other diagnostic tests.

April 21, 2025

ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology

ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing.

Illustration

The U.S. District Court for the Eastern District of Texas today struck down the FDA’s final rule to regulate laboratory-developed tests.

March 31, 2025

ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating

The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said.

Pramana and ARUP logos

March 11, 2025

Pramana and ARUP Laboratories Partner To Digitize Pathology Slides and Develop AI-Powered

Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.

A robotic arm holds a wet-mount specimen slide.

The robotic arm removes the wet-mount specimen slide in preparation for scanning. Once scanned, the image will be screened via artificial intelligence (AI) for evidence of ova and parasites.

March 6, 2025

ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis

ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process.

Text text text

The partnership combines Tasso’s clinical grade blood collection solutions, such as the Tasso+ device pictured above, with ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.

February 3, 2025

Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research

The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.